Calidi Biotherapeutics, Inc. (CLDI)
SG&A Expense Growth
-0.50%
Quarterly · Period ending:
CLDI SG&A Expense Growth
Latest reported-0.50%period ending
Latest reported-0.50%period ending
CLDI Quarterly SG&A Growth (QoQ) (0.00% → -0.50%)
Latest values, visible window
High-resolution chart · PNG
CLDI sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -0.5% | |
| -24.0987% | |
| -21.5482% | |
| -12.5041% | |
| 16.4581% | |
| 45.0495% | |
| -40.8396% | |
| -14.7573% | |
| -0.8253% | |
| -33.885% | |
| 42.0672% | |
| 15.1786% | |
| 20.3438% | |
| -57.8566% | |
| 110.9201% | |
| 8.3851% | |
| -15.7068% | |
| 76.7609% | |
| 77.645% | |
| 10,848.8% | |
| 0% |